Shares of Amgen Inc. AMGN slipped 0.68% to $275.75 Tuesday, on what proved to be an all-around dismal trading session for the ...

Amgen (NASDAQ:AMGN) declares $2.38/share quarterly dividend, 5.8% increase from prior dividend of $2.25. Forward yield 3.45% ...

Furthermore, the biotech's dividend program remains compelling despite near-term headwinds. Therefore, Amgen's combination of ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

U.S. drugmaker Amgen said on Thursday it will invest $1 billion towards a second drug substance manufacturing facility in ...

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...

Biopharmaceutical company Amgen, Inc. on Thursday announced a $1 billion manufacturing expansion in Holly Springs, which it ...

Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $380.00. The company’s ...

Ten years after its first FDA approval, Amgen’s Blincyto continues to make inroads in treating acute lymphoblastic leukemia. | Investigators halted study randomization early based on the strong ...

Analysts have recently evaluated Amgen and provided 12-month price targets. The average target is $340.38, accompanied by a high estimate of $405.00 and a low estimate of $215.00. This upward trend is ...